These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 15837762)
1. In vivo effects of the human type I insulin-like growth factor receptor antibody A12 on androgen-dependent and androgen-independent xenograft human prostate tumors. Wu JD; Odman A; Higgins LM; Haugk K; Vessella R; Ludwig DL; Plymate SR Clin Cancer Res; 2005 Apr; 11(8):3065-74. PubMed ID: 15837762 [TBL] [Abstract][Full Text] [Related]
2. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma. Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627 [TBL] [Abstract][Full Text] [Related]
3. Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumors. Wu JD; Haugk K; Coleman I; Woodke L; Vessella R; Nelson P; Montgomery RB; Ludwig DL; Plymate SR Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6153-60. PubMed ID: 17062692 [TBL] [Abstract][Full Text] [Related]
4. An antibody targeting the type I insulin-like growth factor receptor enhances the castration-induced response in androgen-dependent prostate cancer. Plymate SR; Haugk K; Coleman I; Woodke L; Vessella R; Nelson P; Montgomery RB; Ludwig DL; Wu JD Clin Cancer Res; 2007 Nov; 13(21):6429-39. PubMed ID: 17975155 [TBL] [Abstract][Full Text] [Related]
5. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo. Burtrum D; Zhu Z; Lu D; Anderson DM; Prewett M; Pereira DS; Bassi R; Abdullah R; Hooper AT; Koo H; Jimenez X; Johnson D; Apblett R; Kussie P; Bohlen P; Witte L; Hicklin DJ; Ludwig DL Cancer Res; 2003 Dec; 63(24):8912-21. PubMed ID: 14695208 [TBL] [Abstract][Full Text] [Related]
6. The combination of antagonists of LHRH with antagonists of GHRH improves inhibition of androgen sensitive MDA-PCa-2b and LuCaP-35 prostate cancers. Stangelberger A; Schally AV; Zarandi M; Heinrich E; Groot K; Havt A; Kanashiro CA; Varga JL; Halmos G Prostate; 2007 Sep; 67(12):1339-53. PubMed ID: 17624923 [TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-I receptor signaling blockade combined with radiation. Allen GW; Saba C; Armstrong EA; Huang SM; Benavente S; Ludwig DL; Hicklin DJ; Harari PM Cancer Res; 2007 Feb; 67(3):1155-62. PubMed ID: 17283150 [TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer. Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559 [TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancer. Furukawa J; Wraight CJ; Freier SM; Peralta E; Atley LM; Monia BP; Gleave ME; Cox ME Prostate; 2010 Feb; 70(2):206-18. PubMed ID: 19790231 [TBL] [Abstract][Full Text] [Related]
10. Targeting IGF-IR with ganitumab inhibits tumorigenesis and increases durability of response to androgen-deprivation therapy in VCaP prostate cancer xenografts. Fahrenholtz CD; Beltran PJ; Burnstein KL Mol Cancer Ther; 2013 Apr; 12(4):394-404. PubMed ID: 23348048 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice. Wallner L; Dai J; Escara-Wilke J; Zhang J; Yao Z; Lu Y; Trikha M; Nemeth JA; Zaki MH; Keller ET Cancer Res; 2006 Mar; 66(6):3087-95. PubMed ID: 16540658 [TBL] [Abstract][Full Text] [Related]
12. Combined targeting of epidermal growth factor receptor and MDM2 by gefitinib and antisense MDM2 cooperatively inhibit hormone-independent prostate cancer. Bianco R; Caputo R; Caputo R; Damiano V; De Placido S; Ficorella C; Agrawal S; Bianco AR; Ciardiello F; Tortora G Clin Cancer Res; 2004 Jul; 10(14):4858-64. PubMed ID: 15269162 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody. Wang Y; Hailey J; Williams D; Wang Y; Lipari P; Malkowski M; Wang X; Xie L; Li G; Saha D; Ling WL; Cannon-Carlson S; Greenberg R; Ramos RA; Shields R; Presta L; Brams P; Bishop WR; Pachter JA Mol Cancer Ther; 2005 Aug; 4(8):1214-21. PubMed ID: 16093437 [TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of SCLC growth by the A12 anti-IGF-1R monoclonal antibody correlates with inhibition of Akt. Yeh J; Litz J; Hauck P; Ludwig DL; Krystal GW Lung Cancer; 2008 May; 60(2):166-74. PubMed ID: 18006183 [TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-I promotes migration in human androgen-independent prostate cancer cells via the alphavbeta3 integrin and PI3-K/Akt signaling. Montagnani Marelli M; Moretti RM; Procacci P; Motta M; Limonta P Int J Oncol; 2006 Mar; 28(3):723-30. PubMed ID: 16465378 [TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of GSK1904529A, a small-molecule inhibitor of the insulin-like growth factor-I receptor tyrosine kinase. Sabbatini P; Rowand JL; Groy A; Korenchuk S; Liu Q; Atkins C; Dumble M; Yang J; Anderson K; Wilson BJ; Emmitte KA; Rabindran SK; Kumar R Clin Cancer Res; 2009 May; 15(9):3058-67. PubMed ID: 19383820 [TBL] [Abstract][Full Text] [Related]
17. Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors. Plymate SR; Tennant MK; Culp SH; Woodke L; Marcelli M; Colman I; Nelson PS; Carroll JM; Roberts CT; Ware JL Prostate; 2004 Nov; 61(3):276-90. PubMed ID: 15368471 [TBL] [Abstract][Full Text] [Related]
18. LuCaP 35: a new model of prostate cancer progression to androgen independence. Corey E; Quinn JE; Buhler KR; Nelson PS; Macoska JA; True LD; Vessella RL Prostate; 2003 Jun; 55(4):239-46. PubMed ID: 12712403 [TBL] [Abstract][Full Text] [Related]
19. Effect of zinc on regulation of insulin-like growth factor signaling in human androgen-independent prostate cancer cells. Banudevi S; Senthilkumar K; Sharmila G; Arunkumar R; Vijayababu MR; Arunakaran J Clin Chim Acta; 2010 Feb; 411(3-4):172-8. PubMed ID: 19913001 [TBL] [Abstract][Full Text] [Related]